A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Ranging Trial of Tafenoquine for Weekly Prophylaxis againstPlasmodium falciparum

Abstract
Tafenoquine is a promising new 8-aminoquinoline drug that may be useful for malaria prophylaxis in non-pregnant persons with normal glucose-6-phospha